Biomarkers Improve Cost-Benefit Analysis of Head and Neck Cancer Immunotherapy
A new economic analysis suggests that the value of pembrolizumab for patients with locally advanced head and neck squamous cell ...
A new economic analysis suggests that the value of pembrolizumab for patients with locally advanced head and neck squamous cell ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine